PL2100968T3 - Sposób produkcji rekombinowanego białka TAT-HOXB4H do zastosowania jako stymulant hematopoezy in vivo - Google Patents

Sposób produkcji rekombinowanego białka TAT-HOXB4H do zastosowania jako stymulant hematopoezy in vivo

Info

Publication number
PL2100968T3
PL2100968T3 PL08153854T PL08153854T PL2100968T3 PL 2100968 T3 PL2100968 T3 PL 2100968T3 PL 08153854 T PL08153854 T PL 08153854T PL 08153854 T PL08153854 T PL 08153854T PL 2100968 T3 PL2100968 T3 PL 2100968T3
Authority
PL
Poland
Prior art keywords
hematopoiesis
stimulant
vivo
producing recombinant
recombinant tat
Prior art date
Application number
PL08153854T
Other languages
English (en)
Inventor
Kou-Juey Wu
Chi-Hung Huang
Original Assignee
Taiwan Advance Bio Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiwan Advance Bio Pharm Inc filed Critical Taiwan Advance Bio Pharm Inc
Publication of PL2100968T3 publication Critical patent/PL2100968T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Water Supply & Treatment (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
PL08153854T 2008-03-04 2008-03-31 Sposób produkcji rekombinowanego białka TAT-HOXB4H do zastosowania jako stymulant hematopoezy in vivo PL2100968T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/042,097 US8222206B2 (en) 2008-03-04 2008-03-04 Method of enhancing the mobilization of hematopoietic stem cells using TAT-HOXB4H
EP08153854.8A EP2100968B1 (en) 2008-03-04 2008-03-31 Method of producing recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo

Publications (1)

Publication Number Publication Date
PL2100968T3 true PL2100968T3 (pl) 2014-08-29

Family

ID=40627112

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12152269T PL2455099T3 (pl) 2008-03-04 2008-03-31 Sposób produkcji rekombinowanego białka tat-hoxb4h do zastosowania jako stymulant hematopoezy in vivo
PL08153854T PL2100968T3 (pl) 2008-03-04 2008-03-31 Sposób produkcji rekombinowanego białka TAT-HOXB4H do zastosowania jako stymulant hematopoezy in vivo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL12152269T PL2455099T3 (pl) 2008-03-04 2008-03-31 Sposób produkcji rekombinowanego białka tat-hoxb4h do zastosowania jako stymulant hematopoezy in vivo

Country Status (14)

Country Link
US (4) US8222206B2 (pl)
EP (2) EP2100968B1 (pl)
JP (2) JP4755224B2 (pl)
KR (1) KR101160381B1 (pl)
CN (3) CN104650210B (pl)
BR (1) BRPI0803381A2 (pl)
CA (1) CA2658231C (pl)
ES (2) ES2567780T3 (pl)
HU (1) HUE027513T2 (pl)
MY (1) MY164521A (pl)
PL (2) PL2455099T3 (pl)
PT (1) PT2100968E (pl)
RU (1) RU2401863C2 (pl)
TW (1) TWI414598B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8222206B2 (en) * 2008-03-04 2012-07-17 Taiwan Advance Bio-Pharm Inc. Method of enhancing the mobilization of hematopoietic stem cells using TAT-HOXB4H
US10354407B2 (en) 2013-03-15 2019-07-16 Spatial Cam Llc Camera for locating hidden objects
US10896327B1 (en) 2013-03-15 2021-01-19 Spatial Cam Llc Device with a camera for locating hidden object
EP3260533B1 (en) * 2011-03-22 2019-09-11 Pluristem Ltd. Methods for treating radiation or chemical injury
RU2495125C2 (ru) * 2011-12-07 2013-10-10 Федеральное государственное бюджетное учреждение "Новосибирский научно-исследовательский институт патологии кровообращения имени академика Е.Н. Мешалкина" Министерства здравоохранения Российской Федерации (ФГБУ "ННИИПК им. акад. Е.Н. Мешалкина" Минздрава России) РЕКОМБИНАНТНАЯ ПЛАЗМИДА pOK-DsRed2, КОДИРУЮЩАЯ БЕЛКИ ОСТ4 И KLF4 ЧЕЛОВЕКА И ФЛУОРЕСЦЕНТНЫЙ БЕЛОК DsRed2, ПРЕДНАЗНАЧЕНАЯ ДЛЯ ПОЛУЧЕНИЯ ИНДУЦИРОВАННЫХ ПЛЮРИПОТЕНТНЫХ СТВОЛОВЫХ КЛЕТОК ЧЕЛОВЕКА
CN105051061B (zh) * 2013-01-30 2020-02-21 康奈尔大学 用于扩增干细胞的组合物和方法
MX2015014053A (es) * 2013-04-05 2016-04-07 Claudia Zylberberg Metaloproteinasas de matriz y sus usos.
TWI548748B (zh) * 2015-04-16 2016-09-11 台灣尖端先進生技醫藥股份有限公司 造血幹／先驅細胞之體外放大培養方法及其立即可使用之組成物
WO2017143210A1 (en) * 2016-02-19 2017-08-24 The General Hospital Corporation Methods for generating universal and custom mhc/hla-compatible hematopoietic progenitor cells
CN112752547A (zh) 2018-09-24 2021-05-04 波士顿科学国际有限公司 具有改进的组织保持的侵略性特征的夹子
TW202026307A (zh) * 2019-01-11 2020-07-16 台灣尖端先進生技醫藥股份有限公司 Ｎ－端標記組胺酸之重組ｔａｔ－ｈｏｘ家族蛋白質及其製造方法
TWI756518B (zh) * 2019-02-27 2022-03-01 台灣尖端先進生技醫藥股份有限公司 突變型ｈｏｘｂ４重組蛋白質之製造方法與用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2838867B2 (ja) * 1986-01-22 1998-12-16 中外製薬株式会社 幹細胞増殖促進剤
JPH0276820A (ja) * 1988-06-15 1990-03-16 Ajinomoto Co Inc 骨髄移植療法支持剤
JPH06133780A (ja) * 1992-10-23 1994-05-17 Sumitomo Pharmaceut Co Ltd 新規なｔ−ＰＡ改変体
US5837507A (en) * 1995-11-13 1998-11-17 The Regents Of The University Of California Hox-induced enhancement of in vivo and in vitro proliferative capacity and gene therapeutic methods
US6303337B1 (en) * 1999-08-25 2001-10-16 Amber Gen. Inc. N-terminal and C-terminal markers in nascent proteins
US20040082003A1 (en) * 2000-02-23 2004-04-29 Guy Sauvageau Stem cell expansion enhancing factor and method of use
US20040072298A1 (en) * 2000-02-23 2004-04-15 Guy Sauvageau Stem cell expansion enhancing factor and method of use
US20020086383A1 (en) * 2000-02-23 2002-07-04 Guy Sauvageau Hematopoietic stem cell expansion enhancing factor and method of use
DE10050935A1 (de) * 2000-10-11 2002-05-02 Tegenero Gmbh Verwendung CD28 spezifischer monoklonaler Antikörper zur Stimulation von Blutzellen, welche kein CD28 tragen
US7138252B2 (en) * 2002-07-17 2006-11-21 Cytos Biotechnology Ag Molecular antigen arrays
CA2501630A1 (en) * 2002-10-08 2004-04-22 Institut De Recherches Cliniques De Montreal Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor
US20040229330A1 (en) 2003-02-27 2004-11-18 Bayer Pharmaceuticals Corporation Integrated method for capture and purification of tagged proteins
JP5517394B2 (ja) * 2003-07-03 2014-06-11 ユニバーシティ オブ サザン カリフォルニア 造血におけるｉｌ−１２の使用
WO2005026196A2 (en) 2003-09-12 2005-03-24 Novexin Limited Methods for folding proteins and reducing protein aggregation
TW200517398A (en) 2003-11-21 2005-06-01 Ind Tech Res Inst Method for recombinant protein purification, modification and immobilization
US20080299095A1 (en) * 2004-07-09 2008-12-04 Bc Cancer Agency Nup98-Hox Fusions for Expansion of Hemopoietic Stem Cells
TWI328036B (en) * 2005-07-01 2010-08-01 Taiwan Advance Bio Pharm Inc Process for producing c-termial histidine tagged hoxb4 and the use thereof in expanding stem cells
CN101016540B (zh) 2006-02-10 2010-04-07 台湾尖端先进生技医药股份有限公司 C-端含有组氨酸标记的hoxb4重组蛋白质的制造方法及用途
CN106434527A (zh) * 2006-04-14 2017-02-22 安斯泰来再生医药协会 血管瘤集落形成细胞
TWI311562B (en) 2006-05-09 2009-07-01 Northern Taiwan Bio Pharm Inc One step rapid desalting and protein refolding process
TWI369990B (en) 2006-09-05 2012-08-11 Taiwan Advance Bio Pharminc Hsc proliferated with c-histidine labeled hoxb4h and use thereof
US8222206B2 (en) * 2008-03-04 2012-07-17 Taiwan Advance Bio-Pharm Inc. Method of enhancing the mobilization of hematopoietic stem cells using TAT-HOXB4H

Also Published As

Publication number Publication date
US20110092450A1 (en) 2011-04-21
HUE027513T2 (en) 2016-10-28
RU2401863C2 (ru) 2010-10-20
EP2455099A1 (en) 2012-05-23
US20110092412A1 (en) 2011-04-21
JP4755224B2 (ja) 2011-08-24
EP2100968B1 (en) 2014-02-26
PL2455099T3 (pl) 2016-07-29
US8450458B2 (en) 2013-05-28
EP2100968A1 (en) 2009-09-16
KR101160381B1 (ko) 2012-06-26
CN102805859B (zh) 2016-06-01
JP2011168597A (ja) 2011-09-01
HK1170933A1 (en) 2013-03-15
CN101524527A (zh) 2009-09-09
CA2658231A1 (en) 2009-09-04
TW200938632A (en) 2009-09-16
US20120322979A1 (en) 2012-12-20
TWI414598B (zh) 2013-11-11
KR20090095473A (ko) 2009-09-09
CN102805859A (zh) 2012-12-05
JP5738636B2 (ja) 2015-06-24
CA2658231C (en) 2014-09-23
BRPI0803381A2 (pt) 2011-08-23
ES2464777T3 (es) 2014-06-04
US8222206B2 (en) 2012-07-17
MY164521A (en) 2017-12-29
US8124377B2 (en) 2012-02-28
HK1130290A1 (en) 2009-12-24
ES2567780T3 (es) 2016-04-26
US20090227496A1 (en) 2009-09-10
CN104650210B (zh) 2018-01-23
EP2455099B1 (en) 2016-01-20
US8222207B2 (en) 2012-07-17
CN101524527B (zh) 2016-06-01
CN104650210A (zh) 2015-05-27
PT2100968E (pt) 2014-05-30
RU2008134247A (ru) 2010-02-27
JP2009207482A (ja) 2009-09-17

Similar Documents

Publication Publication Date Title
PL2455099T3 (pl) Sposób produkcji rekombinowanego białka tat-hoxb4h do zastosowania jako stymulant hematopoezy in vivo
ZA201008170B (en) Polypeptides and methods for producing triacyglycerols comprising modified fatty acids
ZA201107702B (en) Composition and methods related to protein a(spa)variants
ZA201102645B (en) Method for delivering a pharmaceutical composition to patient in need thereof
EP2242767A4 (en) PROCESS FOR OBTAINING PURIFIED HETEROLOGOUS INSULINS EXPRESSED IN YEASTS
PT2407439E (pt) Processo para fabricação de restaurações dentárias
IL211310A0 (en) Method for producing double-crosslinked collagen
PT2249740E (pt) Implante dentário e método para a sua produção
EP2363471A4 (en) IMMUNOASSAY METHOD FOR HUMAN CXCL1 PROTEIN
EP2123435A4 (en) METHOD FOR COMPRESSION MOLDING DISPOSABLE WAFER
IL212123A0 (en) Method of making biologically active alpha-beta peptides
IL209919A0 (en) Process for preparing caspofungin and intermediates thereof
IL209167A0 (en) Protein refolding method
EP2374888A4 (en) PROCESS FOR PRODUCING RECOMBINANT HUMAN INSULIN
PL2462237T3 (pl) Sposoby polepszania wyrażania białka rekombinowanego
EP2412704A4 (en) PROCESS FOR OBTAINING OPTICALLY PURE AMINO ACIDS
EP2179038A4 (en) PROCESS FOR PREPARING RECOMBINANT HUMAN THROMBIN '644
IL212078A0 (en) Antibodies to modified human igf-1/e peptides
GB2466653B (en) Use of a Blood Hydrolysate as a Cement Material
IL197470A0 (en) Method for producing insulin in the form of an oral preparation
GB2460283B (en) Method of producing fibrillar proteins
SI2396410T1 (sl) Postopek za izdelovanje proteina
EP2255187A4 (en) METHOD FOR ASSESSING THE STABILITY OF PROTEINS
EP2363472A4 (en) METHOD FOR AMPLIFYING EXPRESSION OF RECOMBINANT PROTEIN
ZA201008447B (en) Artificial protein scaffolds